Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.33963/KP.15586 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Fulminant Myocarditis Presenting With Refractory Ventricular Fibrillation During BRAF/MEK Inhibitor Therapy.
JACC Case Rep
August 2025
Center for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Trieste, Italy; Division of Card
Background: Myocarditis is a rare but potentially fatal complication of BRAF/MEK inhibitor therapy. Early detection through vigilant monitoring is crucial.
Case Summary: A 35-year-old woman with stage IIIB melanoma treated with adjuvant trametinib and dabrafenib suffered a cardiac arrest due to refractory ventricular fibrillation.
Integrating imaging and invasive pressure data into a multi-scale whole-heart model.
J Biomech Eng
August 2025
National Heart and Lung Institute, Imperial College London, London W12 0NN, UK & The Alan Turing Institute, The British Library, London NW1 2DB, UK.
Cardiovascular diseases are the leading cause of death. Clinical data used to decide treatment are hard to integrate and interpret, making optimal treatment selection difficult. Personalised models can be used to integrate clinical data into a physics and physiology-constrained framework, but their clinical application faces limitations due to complex calibration and validation.
View Article and Find Full Text PDFBiventricular assist device (Berlin Heart EXCOR) as a bridge for heart transplantation.
Multimed Man Cardiothorac Surg
August 2025
Center for Surgery of the Aorta, Coronary and Peripheral Arteries, Meshalkin National Medical Research Center Ministry of Health of Russian Federation, Novosibirsk, Russian Federation
The Berlin Heart EXCOR Adult biventricular assist device (BiVAD) is an approved option for mechanical circulatory support in patients experiencing end-stage biventricular heart failure. In this video tutorial we demonstrate a clinical case of BiVAD EXCOR implantation in an adult.
View Article and Find Full Text PDFDefying the Odds: Survival After Amniotic Fluid Embolism and Extracorporeal Membrane Oxygenation Support.
JACC Case Rep
August 2025
Department of Advanced Heart Failure, Cardiovascular Institute, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA; Department of Interventional Cardiology, Cardiovascular Institute, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA. Electronic address:
Background: Amniotic fluid embolism is a rare potential complication in the peripartum period.
Case Summary: A 27-year-old nulliparous woman presented for elective induction at 41 weeks' gestation. Due to nonreassuring fetal heart tracing, the patient underwent emergent caesarean section complicated by pulseless electrical activity arrest secondary to suspected amniotic fluid embolism after fetus delivery.
ECPELLA as a Bridge to Unexpected Myocardial Recovery in a Patient in Refractory Cardiogenic Shock.
JACC Case Rep
August 2025
Department of Cardiovascular Disease, Inova Schar Heart and Vascular, Inova Fairfax Medical Campus, Falls Church, Virginia, USA. Electronic address:
Cardiogenic shock (CS) is a complex, multifactorial syndrome with substantial morbidity and mortality. Despite neutral results from randomized controlled trials, venoarterial extracorporeal membrane oxygenation (VA-ECMO) may be reasonable for select patients with refractory CS. A 37-year-old woman with morbid obesity and dilated nonischemic cardiomyopathy presented with Society of Cardiovascular Angiography and Intervention stage D biventricular CS, requiring vasopressor support and emergent escalation to ECPELLA, the combination of VA-ECMO and Impella (Abiomed), as a bridge to decision.
View Article and Find Full Text PDF